Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wakisaka, N.
Right arrow Articles by Pagano, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wakisaka, N.
Right arrow Articles by Pagano, J. S.
[Cancer Research 62, 6337-6344, November 1, 2002]
© 2002 American Association for Cancer Research


Tumor Biology

Epstein-Barr Virus Latent Membrane Protein 1 Induces and Causes Release of Fibroblast Growth Factor-21

Naohiro Wakisaka, Shigeyuki Murono, Tomokazu Yoshizaki, Mitsuru Furukawa and Joseph S. Pagano2

Lineberger Comprehensive Cancer Center [N. W., J. S. P.] and Departments of Medicine [J. S. P.] and Microbiology and Immunology [J. S. P.], University of North Carolina at Chapel Hill, North Carolina 27599-7295, and Department of Otolaryngology, School of Medicine, Kanazawa University, Ishikawa 920-8640, Japan [N. W., S. M., T. Y., M. F.]

We have shown that the EBV oncoprotein, latent membrane protein 1 (LMP1), induces a constellation of tumor-invasiveness factors. Fibroblast growth factor (FGF)-2 is angiogenic as well mitogenic. Although FGF-2 does not contain a hydrophobic signal sequence for secretion, FGF-2 is released extracellularly. However, the mechanism by which FGF-2 is released is unclear. Here we show first that LMP1 induces in epithelial cells the expression of FGF-2 mRNA and protein through both LMP1 COOH-terminal activation domains, CTAR 1 and CTAR 2, which can activate nuclear factor (NF)-{kappa}B signaling and also the p38 mitogen-activated protein kinase pathway. Coexpression of I{kappa}B{alpha} (S32A/S36A), which cannot be phosphorylated and prevents NF-{kappa}B activation, with LMP1 inhibited induction of FGF-2 by LMP1, which suggests that LMP1 induces FGF-2 via NF-{kappa}B signaling. Moreover, unlike phorbol 12-myristate 13-acetate LMP1 also induced the release of the Mr 18,000 isoform of FGF-2 protein. Transfection of Ad-AH cells with LMP1 deletion mutants lacking either CTAR 1 or CTAR 2 also induced the release of the protein. Secretion was confirmed in 293 cells, which do not contain detectable endogenous FGF-2 protein, cotransfected with FGF-2 and LMP1. Finally, Na+/K+-ATPase participates in FGF-2 release, independently of the classical endoplasmic reticulum/Golgi pathway. In this study, the release of Mr 18,000 FGF-2 protein was partially suppressed by ouabain, which inhibits the activity of Na+/K+-ATPase {alpha}1 subunit, but not by Brefeldin A, which inhibits the endoplasmic reticulum/Golgi-dependent secretory pathway. In contrast, the release of Mr 18,000 FGF-2 protein was almost completely inhibited by I{kappa}B{alpha} (S32A/S36A). These results suggest that FGF-2 release is independently mediated by NF-{kappa}B signaling, not simply a consequence of induction itself. Thus, NF-{kappa}B signaling is involved in induction of expression and release of FGF-2 by LMP1.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
A. Tsuji, N. Wakisaka, S. Kondo, S. Murono, M. Furukawa, and T. Yoshizaki
Induction of Receptor for Advanced Glycation End Products by EBV Latent Membrane Protein 1 and Its Correlation with Angiogenesis and Cervical Lymph Node Metastasis in Nasopharyngeal Carcinoma
Clin. Cancer Res., September 1, 2008; 14(17): 5368 - 5375.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Xu, T. Coleman, J. Zhang, A. Fagot, C. Kotalik, L. Zhao, P. Trivedi, C. Jones, and L. Zhang
Epstein-Barr Virus Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication in Primary Effusion Lymphomas
J. Virol., June 1, 2007; 81(11): 6068 - 6078.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Horikawa, J. Yang, S. Kondo, T. Yoshizaki, I. Joab, M. Furukawa, and J. S. Pagano
Twist and Epithelial-Mesenchymal Transition Are Induced by the EBV Oncoprotein Latent Membrane Protein 1 and Are Associated with Metastatic Nasopharyngeal Carcinoma
Cancer Res., March 1, 2007; 67(5): 1970 - 1978.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Kondo, T. Yoshizaki, N. Wakisaka, T. Horikawa, S. Murono, K. L. Jang, I. Joab, M. Furukawa, and J. S. Pagano
MUC1 Induced by Epstein-Barr Virus Latent Membrane Protein 1 Causes Dissociation of the Cell-Matrix Interaction and Cellular Invasiveness via STAT Signaling
J. Virol., February 15, 2007; 81(4): 1554 - 1562.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Kondo, S. Y. Seo, T. Yoshizaki, N. Wakisaka, M. Furukawa, I. Joab, K. L. Jang, and J. S. Pagano
EBV Latent Membrane Protein 1 Up-regulates Hypoxia-Inducible Factor 1{alpha} through Siah1-Mediated Down-regulation of Prolyl Hydroxylases 1 and 3 in Nasopharyngeal Epithelial Cells.
Cancer Res., October 15, 2006; 66(20): 9870 - 9877.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Li, H. Guo, X. Luo, J. Sheng, S. Yang, Y. Yin, J. Zhou, and J. Zhou
Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons
FASEB J, June 1, 2006; 20(8): 1263 - 1265.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Arbach, V. Viglasky, F. Lefeu, J.-M. Guinebretiere, V. Ramirez, N. Bride, N. Boualaga, T. Bauchet, J.-P. Peyrat, M.-C. Mathieu, et al.
Epstein-Barr Virus (EBV) Genome and Expression in Breast Cancer Tissue: Effect of EBV Infection of Breast Cancer Cells on Resistance to Paclitaxel (Taxol)
J. Virol., January 15, 2006; 80(2): 845 - 853.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Tanaka, J. Hasegawa, K. Asamitsu, and T. Okamoto
Prevention of the Ultraviolet B-Mediated Skin Photoaging by a Nuclear Factor {kappa}B Inhibitor, Parthenolide
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 624 - 630.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Zhang, J. Zhang, Q. Lambert, C. J. Der, L. Del Valle, J. Miklossy, K. Khalili, Y. Zhou, and J. S. Pagano
Interferon Regulatory Factor 7 Is Associated with Epstein-Barr Virus-Transformed Central Nervous System Lymphoma and Has Oncogenic Properties
J. Virol., December 1, 2004; 78(23): 12987 - 12995.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. Wakisaka, S. Kondo, T. Yoshizaki, S. Murono, M. Furukawa, and J. S. Pagano
Epstein-Barr Virus Latent Membrane Protein 1 Induces Synthesis of Hypoxia-Inducible Factor 1{alpha}
Mol. Cell. Biol., June 15, 2004; 24(12): 5223 - 5234.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Wang, N. Wakisaka, C. C Tomlinson, S. M DeWire, S. Krall, J. S Pagano, and B. Damania
The Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8) K1 Protein Induces Expression of Angiogenic and Invasion Factors
Cancer Res., April 15, 2004; 64(8): 2774 - 2781.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Ning, A. M. Hahn, L. E. Huye, and J. S. Pagano
Interferon Regulatory Factor 7 Regulates Expression of Epstein-Barr Virus Latent Membrane Protein 1: a Regulatory Circuit
J. Virol., September 1, 2003; 77(17): 9359 - 9368.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.